In 2015, N-terminally truncated variants of the C-terminally truncated and fully bioactive GIP(1-30)NH 2 were studied
Differences in total costs were $40,536 and $42,515 comparing pruritus and fatigue cases with controls, respectively, and largely driven by inpatient (IP) costs ($24,571 and $25,746 for pruritus and fatigue cases with controls, respectively)
A., Habener, J
82560591, 82460510, 82203565, 82103388, 31960145), Yunnan province applied research funds (202201AY070001-011, 202201AY070001-043, and 202301AS07001), the Science and Technology Innovation Team of Tumor Metabolism Research, Kunming Medical University (CXTD202102), and Scientific Research Fund of the Education Department of Yunnan Province (2025S004)
Therefore, the rising prevalence of diabetes is driving the GLP-1 receptor agonist industry